Publication Name	World Journal of Medical Genetics
Manuscript ID	86616
Country	Australia

Received	2023-06-28 04:23
Peer-Review Started	2023-06-28 04:23
First Decision by Editorial Office Director	2023-08-31 07:00
Return for Revision	2023-08-31 07:00
Revised	2023-11-06 22:04
Publication Fee Transferred
Second Decision by Editor	2023-11-16 13:28
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2023-11-30 05:33
Articles in Press	2023-11-30 05:33
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-12-20 03:21
Publish the Manuscript Online	2023-12-20 11:30

ISSN	2220-3184 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Health Care Sciences & Services
Manuscript Type	Retrospective Study
Article Title	Clinical utilities and end-user experience of pharmacogenomics: 39 mo of clinical implementation experience in an Australian hospital setting
Manuscript Source	Unsolicited Manuscript
All Author List	Rosalind Moxham, Andrew Tjokrowidjaja, Sophie Devery, Renee Smyth, Alison McLean, Darren M Roberts and Kathy HC Wu
ORCID	Author(s) ORCID Number Rosalind Moxham http://orcid.org/0001-7331-9758 Alison McLean http://orcid.org/0001-9715-166 Kathy HC Wu http://orcid.org/0002-7405-8788
Funding Agency and Grant Number	Funding Agency Grant Number Partially funded by St Vincent’s Health Australia Inclusive Health Program; Early Career Research Grant from Avant.
Corresponding Author	Kathy HC Wu, Founder, FRACP, MBBS, MMed, Associate Professor, Clinical Genomics, St Vincent's Hospital , Translational Research Centre, No. 97-105 Boundary Street, Darlinghurst, Sydney 2010, NSW, Australia. kathy.wu@svha.org.au
Key Words	Pharmacogenomics testing; Clinical adoption; Drug gene interactions; Clinician perspectives; Patient perspectives
Core Tip	Pharmacogenomics (PG)-guided therapy has the potential to reduce adverse drug reactions and improve clinical outcomes of patients with mental illness. Despite increasing evidence, the uptake of PG among Australian clinicians remains low. We report for the first time on the dichotomous responses between patients and their clinician counterparts in the usage of PG: Patients were generally positive and willing to use PG compared with clinicians, suggesting that the uptake of PG in Australia is likely to be driven by patients, and that clinicians need to be prepared to provide information and guidance to their patients.
Publish Date	2023-12-20 11:30
Citation	Moxham R, Tjokrowidjaja A, Devery S, Smyth R, McLean A, Roberts DM, Wu KHC. Clinical utilities and end-user experience of pharmacogenomics: 39 mo of clinical implementation experience in an Australian hospital setting. World J Med Genet 2023; 11(4): 39-50
URL	https://www.wjgnet.com/2220-3184/full/v11/i4/39.htm
DOI	https://dx.doi.org/10.5496/wjmg.v11.i4.39

Full Article (PDF)	WJMG-11-39-with-cover.pdf
Full Article (Word)	WJMG-11-39.docx